华氏巨球蛋白血症

预约门诊

生存率

华氏巨球蛋白血症的生存率按风险分组判定。其他癌症可能按分期判定生存率，但分期并不适用于华氏巨球蛋白血症。医疗护理专业人员使用风险分组来描述这种癌症的严重程度。

为了确定风险分组，医疗护理团队会使用患者的年龄以及白蛋白和乳酸脱氢酶（LDH）这两项血液检测的结果。低危组患者的生存期往往更长，高危组患者死于华氏巨球蛋白血症的概率更高。

生存率是指该类癌症患者在确诊后一定年限仍然存活的百分比。举例来说，五年生存率是指确诊后五年仍然存活的患者百分比。

各风险分组的五年生存率估计值如下：

  • 低危组：约 93%。
  • 中低危组：约 82%。
  • 中危组：约 69%。
  • 高危组：约 55%。

请注意，生存率统计数据需要五年才能采集到。最新的生存率数据包含五年前接受过华氏巨球蛋白血症治疗的患者。这些患者可能未接受过最新疗法。

申请预约
诊断与治疗医生与科室
Dec. 20, 2025

Living with 华氏巨球蛋白血症?

Connect with others like you for support and answers to your questions in the Blood Cancers & Disorders support group on Mayo Clinic Connect, a patient community.

Blood Cancers & Disorders Discussions

jak2mpnpositive
I have JAK2 ET and MPN: Anyone else have these symptoms?

113 Replies Sun, Aug 02, 2026

eddb
Anyone else find the side effects of Hydrea 500MG frightening?

212 Replies Sun, Aug 02, 2026

Lori, Volunteer Mentor
My Bone Marrow Transplant (BMT/SCT) story: Will you share yours?

912 Replies Fri, Jul 31, 2026

See more discussions
  1. Waldenstrom macroglobulinemia/lymphoplasmacytic lymphoma. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1475. Accessed Nov. 3, 2025.
  2. Epidemiology, pathogenesis, clinical manifestations, and diagnosis of Waldenstrom macroglobulinemia. https://www.uptodate.com/contents/search. Accessed Nov. 3, 2025.
  3. Clinical manifestations, pathologic features, and diagnosis of lymphoplasmacytic lymphoma. https://www.uptodate.com/contents/search. Accessed Nov. 3, 2025.
  4. Treatment and prognosis of Waldenstrom macroglobulinemia. https://www.uptodate.com/contents/search. Accessed Nov. 3, 2025.
  5. Elsevier Point of Care. Clinical Overview: Waldenstrom macroglobulinemia. https://www.clinicalkey.com. Accessed Nov. 3, 2025.
  6. Ferri FF. Waldenstrom macroglobulinemia. In: Ferri's Clinical Advisor 2026. Elsevier; 2026. https://www.clinicalkey.com. Accessed Nov. 3, 2025.
  7. Nimmagadda R. EPSi. Mayo Clinic. May 5, 2022.
  8. Elsevier Point of Care. Clinical Overview: Hyperviscosity syndrome. https://www.clinicalkey.com. Accessed Nov. 3, 2025.
  9. Prognosis in Waldenstrom's macroglobulinemia. International Waldenstrom's Macroglobulinemia Foundation. https://iwmf.com/prognosis. Accessed Nov. 13, 2025.

相关

相关医疗程序

产品与服务

华氏巨球蛋白血症